We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SNPX market cap is 4.31M. The company's latest EPS is USD -10.1644 and P/E is -0.29.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.43M | -2.13M | -1.7M | -1.59M | -1.37M |
| Net Income | -362k | -1.23M | -425k | -1.43M | -6.05M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.51M | -11.16M | -12.62M | -16.14M | -8.31M |
| Net Income | -15.14M | -15.13M | -12.61M | -5.69M | -13.78M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 32.36M | 31.11M | 29.4M | 28.39M | 22.83M |
| Total Liabilities | 3.93M | 5.53M | 6.52M | 9.59M | 9.71M |
| Total Equity | 26.74M | 24.35M | 22.05M | 18.8M | 12.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.9M | 6.75M | 35.53M | 38.61M | 31.11M |
| Total Liabilities | 479k | 1.61M | 2M | 3.19M | 5.53M |
| Total Equity | 17.42M | 5.14M | 33.53M | 32.69M | 24.35M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.11M | -5.17M | -1.83M | -2.69M | -3.72M |
| Investing | -3k | -2M | -500k | -1M | -1M |
| Financing | -1.64M | -1.64M | N/A | N/A | -4.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.89M | -8.1M | -8.71M | -11.21M | -5.17M |
| Investing | -5k | -5k | -3k | -7k | -2M |
| Financing | 420k | -3.48M | 37.13M | 14.48M | -1.64M |
| Market Cap | 4.31M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.14 |
| Price to Book Ratio | 0.16 |
| Dividend Yield | - |
| Shares Outstanding | 1.36M |
| Average Volume (1 week) | 8.45k |
| Average Volume (1 Month) | 8.69k |
| 52 Week Change | -33.05% |
| 52 Week High | 7.2225 |
| 52 Week Low | 2.32 |
| Spread (Intraday) | 0.15 (4.78%) |
| Company Name | Synaptogenix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.synaptogen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
